Chronic therapy with citalopram decreases regional cerebral glucose utilization in OBX, and not sham-operated, rats: An autoradiographic study

Psychopharmacology

Volumn 207, Issue 2, 2009, Pages 315-323

  Skelin, Ivan ^a,b   Sato, Hiroki ^a,c   Kovačević, Tomislav ^a   Diksic, Mirko ^a,d  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF SPLIT   (Croatia)

^c UNIVERSITY OF YAMANASHI   (Japan)

^d JOSIP JURAJ STROSSMAYER UNIVERSITY OF OSIJEK   (Croatia)

Author keywords

2 14C deoxyglucose; Autoradiography; Cerebral glucose utilization; Citalopram; Model of depression; Olfactory bulbectomy; Serotonin

Indexed keywords

CITALOPRAM; DEOXYGLUCOSE; DEOXYGLUCOSE C 14; GLUCOSE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; BEHAVIOR; BRAIN REGION; CINGULATE GYRUS; COMPARATIVE STUDY; CONTROLLED STUDY; FOREBRAIN; FRONTAL CORTEX; GLUCOSE BRAIN LEVEL; GLUCOSE UTILIZATION; IMPLANT; MALE; NONHUMAN; OLFACTORY BULBECTOMY; OLFACTORY NUCLEUS; ORBITAL CORTEX; OSMOTIC MINIPUMP; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SHAM PROCEDURE; SPRAGUE DAWLEY RAT; SUBSTANTIA NIGRA; TREATMENT DURATION; VISUAL CORTEX;

ANIMALS; AUTORADIOGRAPHY; BRAIN; CITALOPRAM; DEOXYGLUCOSE; DRUG ADMINISTRATION SCHEDULE; INFUSION PUMPS, IMPLANTABLE; LINEAR MODELS; MALE; OLFACTORY BULB; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN UPTAKE INHIBITORS;

EID: 70449521968     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1659-4     Document Type: Article

References (48)

1. SB Auerbach S Hjorth 1995 Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo Naunyn Schmiedebergs Arch Pharmacol 352 597 606 10.1007/BF00171317 1:CAS:528:DyaK28XivFartw%3D%3D 9053730
2. N Bel F Artigas 1993 Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei Synapse 15 243 245 10.1002/syn.890150310 1:CAS:528:DyaK2cXitVynsrs%3D 7506449 (Pubitemid 23339517)
3. MS Buchsbaum J Wu BV Siegel E Hackett M Trenary L Abel C Reynolds 1997 Effect of sertraline on regional metabolic rate in patients with affective disorder Biol Psychiatry 41 15 22 10.1016/S0006-3223(96)00097-2 1:CAS:528:DyaK2sXhsVOiurw%3D 8988791 (Pubitemid 27050641)
4. S Caldecott-Hazard J Mazziotta M Phelps 1988 Cerebral correlates of depressed behavior in rats, visualized using 14C-2-deoxyglucose autoradiography J Neurosci 8 6 1951 1961 1:CAS:528:DyaL1cXksFalt7w%3D 3385484
5. RM Cooper GA Thurlow 1985 Depression and recovery of metabolic activity in rat visual system after eye removal Exp Neurol 89 2 322 336 10.1016/0014-4886(85)90093-7 1:STN:280:DyaL2M3lsl2luw%3D%3D 4018204 (Pubitemid 15040903)
6. GE Duncan KB Johnson GR Breese 1993 Topographic patterns of brain activity in response to swim stress: assessment by 2-deoxyglucose uptake and expression of Fos-like immunoreactivity J Neurosci 13 9 3932 3943 1:CAS:528:DyaK3sXms1Onur8%3D 8366353
7. GE Duncan DJ Knapp KB Johnson GR Breese 1996 Functional classification of antidepressants based on antagonism of swim stress-induced fos-like immunoreactivity J Pharmacol Exp Ther 277 2 1076 1089 1:CAS:528: DyaK28XivFehtLY%3D 8627519
8. B Earley M Glennon M Lally BE Leonard JL Junien 1994 Autoradiographic distribution of cholinergic muscarinic receptors and serotonin(2) receptors in olfactory bulbectomized (OB) rats after chronic treatment with mianserin and desipramine Hum Psychopharmacol 9 397 407 10.1002/hup.470090603 1:CAS:528:DyaK2MXktlejtrk%3D
9. D Eidelberg JR Moeller V Dhawan JJ Sidtis JZ Ginos SC Strother J Cedarbaum P Greene S Fahn DA Rottenberg 1990 The metabolic anatomy of Parkinson's disease: complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies Mov Disord 5 3 203 213 10.1002/mds.870050304 1:STN:280:DyaK3czls1SgsA%3D%3D 2117706
10. NL Foster S Minoshima J Johanns R Little ML Heumann DE Kuhl S Gilman 2000 PET measures of benzodiazepine receptors in progressive supranuclear palsy Neurology 54 9 1768 1773 1:CAS:528:DC%2BD3cXktVCnu78%3D 10802782
11. U Freo 1996 Cerebral metabolic effects of serotonin drugs and neurotoxins Life Sci 59 877 891 10.1016/0024-3205(96)00293-7 1:CAS:528:DyaK28XltV2rsbk%3D 8795699 (Pubitemid 26264456)
12. U Freo C Ori M Dam A Merico G Pizzolato 2000 Effects of acute and chronic treatment with fluoxetine on regional glucose cerebral metabolism in rats: implications for clinical therapies Brain Res 854 35 41 10.1016/S0006-8993(99) 02261-1 1:CAS:528:DC%2BD3cXhtlyisbo%3D 10784104 (Pubitemid 30067658)
13. U Freo A Merico M Ermani C Ori 2008 Cerebral metabolic effects of fluoxetine, fluvoxamine, paroxetine and sertraline in the conscious rat Neurosci Lett. 436 2 148 152 10.1016/j.neulet.2008.03.009 1:CAS:528:DC%2BD1cXkvVyitro%3D 18387742
14. S Hasegawa A Watanabe KQ Nguyen G Debonnel M Diksic 2005 Chronic administration of citalopram in olfactory bulbectomy rats restores brain 5-HT synthesis rates: an autoradiographic study Psychopharmacology (Berl) 179 781 790 10.1007/s00213-004-2122-1 1:CAS:528:DC%2BD2MXjvF2ks70%3D (Pubitemid 40767898)
15. VA Holthoff B Beuthien-Baumann G Zundorf A Triemer S Ludecke P Winiecki R Koch F Fuchtner K Herholz 2004 Changes in brain metabolism associated with remission in unipolar major depression Acta Psychiatr Scand 110 184 194 10.1111/j.1600-0447.2004.00351.x 1:CAS:528:DC%2BD2cXnvVymtrk%3D 15283738 (Pubitemid 39120321)
16. J Hyttel 1994 Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs) Int Clin Psychopharmacol 9 Suppl 1 19 26 8021435
17. R Invernizzi M Bramante R Samanin 1994 Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output: role of presynaptic 5-HT1A receptors Eur J Pharmacol 260 243 246 10.1016/0014-2999(94) 90344-1 1:CAS:528:DyaK2cXlt1Gju7c%3D 7988650 (Pubitemid 24240028)
18. M Jueptner C Weiller 1995 Review: does measurement of regional cerebral blood flow reflect synaptic activity? Implications for PET and fMRI Neuroimage 2 148 156 10.1006/nimg.1995.1017 1:STN:280:DyaK1c%2FgtlCrsA%3D%3D 9343597
19. M Kadekaro AM Crane L Sokoloff 1985 Differential effects of electrical stimulation of sciatic nerve on metabolic activity in spinal cord and dorsal root ganglion in the rat Proc Natl Acad Sci USA 82 6010 6013 10.1073/pnas.82.17.6010 1:CAS:528:DyaL2MXltl2ntrg%3D 3862113 (Pubitemid 16218892)
20. JP Kelly AS Wrynn BE Leonard 1997 The olfactory bulbectomized rat as a model of depression: an update Pharmacol Ther 74 299 316 10.1016/S0163-7258(97) 00004-1 1:CAS:528:DyaK2sXmsFCgsL4%3D 9352586 (Pubitemid 27425352)
21. SH Kennedy M Javanmard FJ Vaccarino 1997 A review of functional neuroimaging in mood disorders: positron emission tomography and depression Can J Psychiatry 42 467 475 1:STN:280:DyaK2szmtlyitQ%3D%3D 9220109
22. SH Kennedy JZ Konarski ZV Segal MA Lau PJ Bieling RS McIntyre HS Mayberg 2007 Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial Am J Psychiatry 164 5 778 788 10.1176/appi.ajp.164.5.778 17475737 (Pubitemid 46808533)
23. SD Kuipers A Trentani C Westenbroek CR Bramham J Korf IP Kema GJ Ter Horst JA Den Boer 2006 Unique patterns of FOS, phospho-CREB and BrdU immunoreactivity in the female rat brain following chronic stress and citalopram treatment Neuropharmacology 50 4 428 440 10.1016/j.neuropharm.2005.10.006 1:CAS:528:DC%2BD28XhtlGmurc%3D 16309718 (Pubitemid 43209039)
24. B Lerer Y Gelfin M Gorfine B Allolio KP Lesch ME Newman 1999 5-HT1A receptor function in normal subjects on clinical doses of fluoxetine: blunted temperature and hormone responses to ipsapirone challenge Neuropsychopharmacology 20 628 639 10.1016/S0893-133X(98)00106-7 1:CAS:528:DyaK1MXjsValsr4%3D 10327431 (Pubitemid 29189266)
25. C Lino-de-Oliveira AJ Sales EA Del Bel MC Silveira FS Guimarães 2001 Effects of acute and chronic fluoxetine treatments on restraint stress-induced Fos expression Brain Res Bull 55 6 747 754 10.1016/S0361-9230(01) 00566-4 1:CAS:528:DC%2BD3MXntlyjtrc%3D 11595358 (Pubitemid 32930077)
26. M Liotti HS Mayberg S McGinnis SL Brannan P Jerabek 2002 Unmasking disease-specific cerebral blood flow abnormalities: mood challenge in patients with remitted unipolar depression Am J Psychiatry 159 1830 1840 10.1176/appi.ajp.159.11.1830 12411216 (Pubitemid 35283247)
27. G Lucas VV Rymar J Du O Mnie-Filali C Bisgaard S Manta L Lambas-Senas O Wiborg N Haddjeri G Pineyro AF Sadikot G Debonnel 2007 Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action Neuron 55 712 725 10.1016/j.neuron.2007.07.041 1:CAS:528:DC%2BD2sXhtV2qtrfI 17785179 (Pubitemid 47334877)
28. DA Marsteller NC Barbarich-Marsteller VD Patel SL Dewey 2007 Brain metabolic changes following 4-week citalopram infusion: increased 18FDG uptake and gamma-amino butyric acid levels Synapse 61 877 881 10.1002/syn.20428 1:CAS:528:DC%2BD2sXhtFaiu7fN 17657806 (Pubitemid 47464083)
29. HS Mayberg SK Brannan JL Tekell JA Silva RK Mahurin S McGinnis PA Jerabek 2000 Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response Biol Psychiatry 48 830 843 10.1016/S0006-3223(00)01036-2 1:CAS:528:DC%2BD3cXns12gurY%3D 11063978 (Pubitemid 30813467)
30. J Moncrieff D Cohen 2005 Rethinking models of psychotropic drug action Psychother Psychosom 74 145 153 10.1159/000083999 15832065 (Pubitemid 41094845)
31. J Moncrieff D Cohen 2006 Do antidepressants cure or create abnormal brain states? PLoS Med 3 e240 10.1371/journal.pmed.0030240 16724872 (Pubitemid 44125974)
32. JI Morgan T Curran 1990 Inducible proto-oncogenes of the nervous system: their contribution to transcription factors and neuroplasticity Prog Brain Res 86 287 294 10.1016/S0079-6123(08)63185-4 1:CAS:528:DyaK3MXit1KhsLg%3D 2128418
33. DA Morilak A Frazer 2004 Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders Int J Neuropsychopharmacol 7 193 218 10.1017/ S1461145704004080 1:CAS:528:DC%2BD2cXjs12mur4%3D 15003145 (Pubitemid 38823288)
34. A Nagano-Saito T Kato Y Arahata Y Washimi A Nakamura Y Abe T Yamada K Iwai K Hatano Y Kawasumi T Kachi A Dagher K Ito 2004 Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies Neuroimage 22 2 553 561 10.1016/j.neuroimage.2004.01.030 15193583 (Pubitemid 38759417)
35. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic, Sydney
36. M Roche A Harkin JP Kelly 2007 Chronic fluoxetine treatment attenuates stressor-induced changes in temperature, heart rate, and neuronal activation in the olfactory bulbectomized rat Neuropsychopharmacology 32 1312 1320 10.1038/sj.npp.1301253 1:CAS:528:DC%2BD2sXltlaqtbo%3D 17119540 (Pubitemid 46788856)
37. H Sato I Skelin G Debonnel M Diksic 2008 Chronic buspirone treatment normalizes open field behavior in olfactory bulbectomized rats: assessment with a quantitative autoradiographic evaluation of the 5-HT1A binding sites Brain Res Bull. 75 5 545 555 10.1016/j.brainresbull.2007.09.005 1:CAS:528: DC%2BD1cXjs1Kktrc%3D 18355630
38. DA Seminowicz HS Mayberg AR McIntosh K Goldapple S Kennedy Z Segal S Rafi-Tari 2004 Limbic-frontal circuitry in major depression: a path modeling meta-analysis Neuroimage 22 1 409 418 10.1016/j.neuroimage.2004.01.015 1:STN:280:DC%2BD2c3htlOktQ%3D%3D 15110034 (Pubitemid 38515850)
39. I Skelin H Sato M Diksic 2008 Olfactory bulbectomy reduces cerebral glucose utilization: 2-[14C]deoxyglucose autoradiographic study Brain Res Bull 76 485 492 10.1016/j.brainresbull.2008.01.020 1:CAS:528:DC%2BD1cXmvFersrk%3D 18534256
40. GS Smith CF Reynolds 3rd B Pollock S Derbyshire E Nofzinger MA Dew PR Houck D Milko CC Meltzer DJ Kupfer 2001 Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression Am J Psychiatry 156 5 683 689
41. L Sokoloff M Reivich C Kennedy MH Des Rosiers CS Patlak KD Pettigrew O Sakurada M Shinohara 1977 The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat J Neurochem 28 897 916 10.1111/j.1471-4159.1977.tb10649.x 1:CAS:528:DyaE2sXltlWiuro%3D 864466
42. D Stanic DI Finkelstein DW Bourke J Drago MK Horne 2003 Timecourse of striatal re-innervation following lesions of dopaminergic SNpc neurons of the rat Eur J Neurosci 18 5 1175 1188 10.1046/j.1460-9568.2003.02800.x 1:STN:280:DC%2BD3svhsl2jtw%3D%3D 12956716 (Pubitemid 37115037)
43. MG van der Hart B Czéh G de Biurrun T Michaelis T Watanabe O Natt J Frahm E Fuchs 2002 Substance P receptor antagonist and clomipramine prevent stress-induced alterations in cerebral metabolites, cytogenesis in the dentate gyrus and hippocampal volume Mol Psychiatry 7 9 933 941 10.1038/sj.mp.4001130 12399945 (Pubitemid 35333047)
44. H van Riezen BE Leonard 1990 Effects of psychotropic drugs on the behavior and neurochemistry of olfactory bulbectomized rats Pharmacol Ther 47 21 34 10.1016/0163-7258(90)90043-2 2195555 (Pubitemid 20183306)
45. JG Veening LM Coolen WJ Spooren H Joosten R van Oorschot J Mos E Ronken B Olivier 1998 Patterns of c-fos expression induced by fluvoxamine are different after acute vs. chronic oral administration Eur Neuropsychopharmacol 8 3 213 226 10.1016/S0924-977X(97)00072-2 1:CAS:528:DyaK1cXjvVSlt7k%3D 9716316 (Pubitemid 28334183)
46. P Videbech 2000 PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review Acta Psychiatr Scand 101 11 20 10.1034/j.1600-0447.2000.101001011.x 1:STN:280:DC%2BD3c7jslCisw%3D%3D 10674946 (Pubitemid 30041119)
47. A Watanabe S Hasegawa K Nishi KQ Nguyen M Diksic 2006 Chronic buspirone treatment normalizes regional serotonin synthesis in the olfactory bulbectomized rat brain: an autoradiographic study Brain Res Bull 69 2 101 108 10.1016/j.brainresbull.2005.11.008 1:CAS:528:DC%2BD28Xit1ymsr0%3D 16533657 (Pubitemid 43375863)
48. D Zhou G Grecksch A Becker C Frank J Pilz G Huether 1998 Serotonergic hyperinnervation of the frontal cortex in an animal model of depression, the bulbectomized rat J Neurosci Res 54 109 116 10.1002/(SICI)1097-4547(19981001)54: 1<109::AID-JNR11>3.0.CO;2-2 1:CAS:528:DyaK1cXmt1yltLw%3D 9778154 (Pubitemid 28447193)